Phase I Study of a Combination of Recombinant Tumor Necrosis Factor-α and Recombinant Interferon-γ in Cancer Patients
Year: 1989
Type: article
Study design: Clinical Trial
Source: Journal of Interferon Research
Institutions: The University of Texas MD Anderson Cancer Center, Genentech
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2011433383
